Patients with growth hormone (GH) insensitivity, typically resulting from mutations affecting the GH receptor (GHR), GHR signaling cascade and insulin-like growth factor-1 (IGF-1) gene, are, generally, unresponsive to GH therapy. Beginning in the 1990’s, clinical trials of IGF-1 administration in such patients demonstrated both short- and long-term efficacy, although not to the degree observed with GH treatment of naïve GH deficient patients. Adverse effects, including hypoglycemia, lymphoid overgrowth, benign intracranial pressure and coarsening of facial features, have been observed, but, in general, have proven to be transient. As demand for IGF-1 treatment for children currently labeled as idiopathic short stature increases, it will be important to have controlled clinical trials of GH, vs. IGF-1 vs. combination GH + IGF-1.
Insulin-Like Growth Factor Treatment of Growth Disorders
Other
Insulin-Like Growth Factor Treatment of Growth Disorders
J Clin Res Pediatr Endocrinol 2015;7(1):3-3
- 1Oregon Health And Sciences University President, Stat5, Llc\R\N
Corresponding Author: Oregon Health And Sciences University President, Stat5, Llc\R\N
Licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
CC BY-NC-ND — Attribution-NonCommercial-NoDerivatives 4.0 InternationalThe statements, opinions, and data contained in articles published in this journal are solely those of the individual author(s) and contributor(s) and do not necessarily reflect the views of the journal, its editors, editorial board, owner, or Galenos Publishing House.
Neither the journal nor Galenos Publishing House endorses or recommends any commercial product, process, service, institution, or organization that may be mentioned or advertised in the journal. The publication of advertisements, product information, or links to external websites does not constitute endorsement or approval by the journal or the publisher.
The journal, its editors, editorial board, owner, and Galenos Publishing House make reasonable efforts to ensure the accuracy and integrity of published content; however, they cannot be held responsible for errors, omissions, or any consequences arising from the use of information contained in the journal, to the extent permitted by applicable law.
Information published in the journal is intended for scientific and educational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Readers should consult appropriately qualified healthcare professionals regarding individual medical conditions or treatment decisions.
External links are provided for informational convenience only. The journal and Galenos Publishing House are not responsible for the availability, accuracy, content, privacy practices, or policies of external websites.
